The Telegraph hailed the GALEAS™ Bladder test as a breakthrough in diagnostics. Read more here bit.ly/3vPXiWN The full article is also available on our website bit.ly/3VZS0mt #BladderCancer #Urology #GALEAS #InformedGenomics

Dive into Bradley's first hand experience at #EAU24! 🚀 From innovative techniques to cutting-edge research, Bradley shares insights that left all urologists eager to learn more. Read his eye-opening recap now: bit.ly/43XrX0S

We’re delighted to share that we have successfully completed a recent UKAS surveillance visit, maintaining our ISO 15189 accreditation for another year!

25th April marks the anniversary of the completion of the human genome project in 2003 and the discovery of the double helix in 1953. Recently appointed CEO, Simon Davis, reflects on how much progress has been made in genomics since then. Read the Q&A here bit.ly/4ba2t2P

We are working with organisations across the private and public sectors to help raise awareness this month for Bladder Cancer. Read our blog to find out what NHS urologist are saying! hubs.ly/Q02vG4XL0

If you're heading to #eshg2024 in Berlin, make sure you come and see the Informed Genomics team at booth 470. We've lots of exciting updates to share about our testing services and our work with the NHS and private healthcare providers to transform healthcare through genomics!

Good morning, Berlin! The Informed Genomics team are heading over to the #eshg2024. Come visit us at booth 470.

A very welcome Victoria Hewitt, who joins us today as Clinical Laboratory Director to head up and support the growth of our fantastic clinical team. We're excited to have her on board! #InformedGenomics #Teamwork #ClinicalServices #BusinessExpansion

#eshg2024 sparked interesting discussions on the provision of #NGS services throughout Europe. Our latest blog post debunks common misconceptions and underscores the significant advantages for European clients working with #InformedGenomics. hubs.ly/Q02BQVQ20

Visit us at 'Developing Partnerships for Innovation in Health' to find out how we can support academic research collaborations and NHS partnerships with our quality-driven genomic testing solutions. hubs.ly/Q02C_SX50. #InformedGenomics #PublicPrivatePartnerships

We are very proud that our Hereditary Cancer service is accredited to ISO 15189, but why should our customers care? Read this great article that compares #UKASaccredited vs non-accredited laboratories. hubs.ly/Q02D09_M0 #HereditaryCancer #InformedGenomics

How are public/private partnerships in genomics streamlining patient pathways and delivering value? Our CEO Simon Davis explains during an interview published in Innovations in Pharmaceutical Technology. hubs.ly/Q02GxSGh0 #PublicPrivatePartnerships #InformedGenomics

Our end-to-end Bladder Cancer service is based on GALEAS Bladder test. In this on-demand webinar, Professor Richard Bryan talks about developing the test, its benefits and what is next. Watch on-demand hubs.ly/Q02KpHMV0 #InformedGenomics #BladderCancer

We are delighted to announce our collaboration with @EMQN CIC to provide tumour profiling to support its quality assurance services, delivering comprehensive next-generation sequencing (#NGS) services. hubs.ly/Q02QT6h70 @GetInformed